# Ritivel

## About

AI-native regulatory platform for life sciences. Draft Clinical Study Reports in minutes, not weeks.

- Founded: 2024
- Verified: Yes

## Services

### Regulatory Compliance Solutions
- [Regulatory Documentation Automation](https://bilarna.com/ai/regulatory-compliance-solutions/regulatory-documentation-automation)

### Life Sciences Data Management
- [Scientific Data Management](https://bilarna.com/services/life-sciences-data-management/scientific-data-and-document-management)

## Frequently Asked Questions

**Q: How can AI improve the drafting process of clinical study reports in life sciences?**
A: AI can significantly enhance the drafting process of clinical study reports by automating the creation of accurate and consistent documents in a fraction of the time it traditionally takes. By leveraging domain-specific language models trained on medical and regulatory content, AI ensures narrative consistency and reduces factual errors. Additionally, AI platforms provide word-level traceability, allowing every statement to be traced back to its source, which supports regulatory scrutiny and audit readiness. This automation not only accelerates submission timelines but also reduces review cycles and internal escalations, enabling regulatory teams to focus more on scientific analysis rather than paperwork.

**Q: What security measures are important for AI platforms handling sensitive regulatory data?**
A: Security is paramount for AI platforms managing sensitive regulatory data, especially in life sciences. Important measures include local deployment to ensure data never leaves the organization's infrastructure, eliminating risks associated with cloud storage or third-party access. Platforms should enforce zero data retention policies and avoid using client data for model training to protect intellectual property. Enterprise-grade security features such as air-gapped readiness allow deployment in isolated environments without external network dependencies. Compliance with internal IT, legal, and data privacy requirements is critical, ensuring that sensitive documents remain confidential and protected against unauthorized access or breaches.

**Q: What types of regulatory documents can be automated using AI in life sciences?**
A: AI can automate a wide range of regulatory documents in life sciences, streamlining the entire submission process. Key documents include Clinical Study Reports (CSRs), Investigational New Drug (IND) applications, New Drug Applications (NDA), Biologics License Applications (BLA), and Common Technical Document (CTD) modules such as Module 2 summaries and Module 5 literature reviews. Additionally, AI supports drafting nonclinical study reports, investigator brochures, statistical analysis plans, tables, listings, figures, protocols, standard operating procedures (SOPs), briefing documents, and safety documentation. Automating these documents reduces manual effort, enhances accuracy, ensures consistency, and accelerates regulatory approvals.

## Links

- Profile: https://bilarna.com/provider/ritivel
- Structured data: https://bilarna.com/provider/ritivel/agent.json
- API schema: https://bilarna.com/provider/ritivel/openapi.yaml